Analyst Ratings For NYSE:TEVA – Teva Pharmaceutical Industries (NYSE:TEVA)
Today, Barclays raised its price target on NYSE:TEVA – Teva Pharmaceutical Industries (NYSE:TEVA) to per share.
Some recent analyst ratings include
- 5/7/2018-Oppenheimer Reiterated Rating of Hold.
- 5/7/2018-Morgan Stanley Reiterated Rating of Equal Weight ➝ Hold.
- 5/3/2018-Maxim Group Reiterated Rating of Hold.
Dividend information for NYSE:TEVA – Teva Pharmaceutical Industries (NYSE:TEVA)
NYSE:TEVA – Teva Pharmaceutical Industries (NYSE:TEVA) pays an annual dividend of $0.43 with a yield of 2.01% and an average dividend growth of -14.40% based on a 3 Year Average..
Dividend History for NYSE:TEVA – Teva Pharmaceutical Industries (NYSE:TEVA)
- On 11/2/2017 NYSE:TEVA – Teva Pharmaceutical Industries announced a quarterly dividend of $0.0850 2.74% with an ex dividend date of 11/27/2017 which will be payable on 12/12/2017.
- On 8/7/2017 NYSE:TEVA – Teva Pharmaceutical Industries announced a quarterly dividend of $0.0850 1.83% with an ex dividend date of 8/25/2017 which will be payable on 9/14/2017.
- On 5/11/2017 NYSE:TEVA – Teva Pharmaceutical Industries announced a quarterly dividend of $0.34 4.28% with an ex dividend date of 6/1/2017 which will be payable on 6/22/2017.
- On 2/13/2017 NYSE:TEVA – Teva Pharmaceutical Industries announced a quarterly dividend of $0.34 3.7% with an ex dividend date of 2/28/2017 which will be payable on 3/20/2017.
- On 11/15/2016 NYSE:TEVA – Teva Pharmaceutical Industries announced a quarterly dividend of $0.34 with an ex dividend date of 12/1/2016 which will be payable on 12/20/2016.
- On 8/4/2016 NYSE:TEVA – Teva Pharmaceutical Industries announced a quarterly dividend of $0.34 with an ex dividend date of 8/18/2016 which will be payable on 9/8/2016.
- On 5/9/2016 NYSE:TEVA – Teva Pharmaceutical Industries announced a quarterly dividend of $0.34 with an ex dividend date of 5/20/2016 which will be payable on 6/7/2016.
Recent Insider Trading Activity For NYSE:TEVA – Teva Pharmaceutical Industries (NYSE:TEVA)
NYSE:TEVA – Teva Pharmaceutical Industries (NYSE:TEVA) has insider ownership of 0.43% and institutional ownership of 64.73%.
- On 5/10/2018 Roberto Mignone, Director, bought 750,000 with an average share price of $19.24 per share and the total transaction amounting to $14,430,000.00.
- On 3/19/2018 Deborah A Griffin, Insider, sold 943 with an average share price of $17.88 per share and the total transaction amounting to $16,860.84.
- On 3/19/2018 Michael James Mcclellan, CFO, sold 287 with an average share price of $17.88 per share and the total transaction amounting to $5,131.56.
- On 3/19/2018 Richard Daniell, VP, sold 1,297 with an average share price of $17.89 per share and the total transaction amounting to $23,203.33.
- On 3/19/2018 Sven Dethlefs, EVP, sold 571 with an average share price of $17.88 per share and the total transaction amounting to $10,209.48.
- On 3/5/2018 Brendan P O’grady, EVP, sold 705 with an average share price of $19.38 per share and the total transaction amounting to $13,662.90.
- On 3/5/2018 Deborah A Griffin, Insider, sold 773 with an average share price of $19.38 per share and the total transaction amounting to $14,980.74.
Recent Trading Activity for NYSE:TEVA – Teva Pharmaceutical Industries (NYSE:TEVA)
Shares of NYSE:TEVA – Teva Pharmaceutical Industries closed the previous trading session at 21.47 up +0.32 1.51% with shares trading hands.